Do you have to worry when biotech giants decide to spend their hard-earned cash repurchasing their own stock rather than using the cash to go purchase new pipelines? That is what we’d…
Douglas A. McIntyre Amgen (NASDAQ:AMGN) had a strong quarter. Biotech has been the most active part of the market in terms of trading volume. Amgen is the category’s grandfather. The company reported EPS of $1.49…
Douglas A. McIntyre Reuters: Apple (NASDAQ:AAPL) beat earnings forecasts. Reuters: The IRS is probing some homebuyers’ tax credit gains. Reuters: The US is ready to bring more insider trading cases. Reuters: More US companies are…
These are this morning’s top day trader alert stocks with more detailed data on price, volume, and further analysis with links to each stock over at VSInvestor.com: Allion Healthcare, Inc. (NASDAQ: ALLI)…
These are the top early-bird analyst upgrades and positive research calls which we have seen from Wall Street early this Monday morning: Advanced Micro Devices (NYSE: AMD) Raised to Buy at UBS.…
Updated throughout the day. Update: Xerox (XRX) may find that IBM (IBM) or HP (HPQ) outbid it for ACS (ACS) (Barron’s) Update: Apple (AAPL) may be working on a touchscreen remote for…
These are this Monday’s top day trader and active trader alert stocks in the pre-market. We have more details on each for volume and price moves at VSInvestor.com: Delta Petroleum Corporation (NASDAQ:…
It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even to sub-sectors within health care. They generally trade…
These are the ten top analyst upgrades,downgrades, and initiations we have seen early this Friday morning with roughly two hours until the market opens: Amgen (AMGN) Cut to Hold at Citigroup. Avery…
These are the top 10 pre-market analyst upgrades and downgrades in Wall Street research calls this Tuesday morning: Amgen (AMGN) Started as Buy at RBC. Brightpoint (CELL) Raised to Buy at Citigroup.…
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis…
Reuters: The recession has badly hurt investments in green technologies. Reuters: Obama called for deeper China ties with the US. Reuters: BP’s (BP) profits fell sharply. Reuters: Bank of America (BAC) will…
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The Medarex…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq: AMGN)’s osteoporosis drug…